Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments
  • Print
  • Share
  • E-mail
-
1 to 6 of 6 Results
Document Number K250741
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Randox Laboratories Ltd., Evidence MultiStat  {Evidence MultiSTAT DOA Urine MultiPlex} 
CR250639 K250741 Amphetamines Toxicology / TDM MODERATE 01/30/2026
Randox Laboratories Ltd., Evidence MultiStat  {Evidence MultiSTAT DOA Urine MultiPlex} 
CR250639 K250741 Cannabinoids (THC) Toxicology / TDM MODERATE 01/30/2026
Randox Laboratories Ltd., Evidence MultiStat  {Evidence MultiSTAT DOA Urine MultiPlex} 
CR250639 K250741 Cocaine metabolites Toxicology / TDM MODERATE 01/30/2026
Randox Laboratories Ltd., Evidence MultiStat  {Evidence MultiSTAT DOA Urine MultiPlex} 
CR250639 K250741 Opiates Toxicology / TDM MODERATE 01/30/2026
Randox Laboratories Ltd., Evidence MultiStat  {Evidence MultiSTAT DOA Urine MultiPlex} 
CR250639 K250741 Fentanyl Toxicology / TDM MODERATE 01/30/2026
Randox Laboratories Ltd., Evidence MultiStat  {Evidence MultiSTAT DOA Urine MultiPlex} (Benzodiazepines 2)
CR250639 K250741 Benzodiazepines Toxicology / TDM MODERATE 01/30/2026

-
-